Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02827071 · ClinicalTrials.gov registry record
Ocular Imaging Study Using Advanced OCT
A clinical trial, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- 150
- Enrollment target
NCT02827071: Clinical Trial study, sponsored by University of California, Los Angeles.
NCT02827071 is a clinical trial that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 150 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02827071 was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if this imaging device and software can improve the quality of images and visualization of imaged tissues and whether they are useful in the diagnosis and treatment of eye diseases. Images collected in this study may be compared to other images collected as part of standard of care on the same patient (OCT, FA, AF, Fundus).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2016-07 |
| Est. Completion | 2021-12-09 |
Why NCT02827071 stopped before completion
NCT02827071 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02827071 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02827071 about?
NCT02827071 is a clinical study titled "Ocular Imaging Study Using Advanced OCT". The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if thi...
What is the current status of trial NCT02827071?
This trial is currently terminated. The enrollment target is 150 participants. The study started on 2016-07. Estimated completion is 2021-12-09.
Who is sponsoring clinical trial NCT02827071?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia